<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Res Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Res Med Sci</journal-id><journal-id journal-id-type="publisher-id">JRMS</journal-id><journal-title-group><journal-title>Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">1735-1995</issn><issn pub-type="epub">1735-7136</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26487877</article-id><article-id pub-id-type="pmc">4590203</article-id><article-id pub-id-type="publisher-id">JRMS-20-477</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effect of Vitamin D supplementation on symptoms and C-reactive protein in migraine patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mottaghi</surname><given-names>Tayebeh</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Askari</surname><given-names>Gholamreza</given-names></name><xref ref-type="aff" rid="aff2">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Khorvash</surname><given-names>Fariborz</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib><contrib contrib-type="author"><name><surname>Maracy</surname><given-names>Mohammad Reza</given-names></name><xref ref-type="aff" rid="aff4">3</xref></contrib></contrib-group><aff id="aff1">Department of Community Nutrition, School of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran</aff><aff id="aff2"><label>1</label>Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</aff><aff id="aff3"><label>2</label>Neuroscience Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran</aff><aff id="aff4"><label>3</label>Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Gholamreza Askari, Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. E-mail: <email xlink:href="askari@mui.ac.ir">askari@mui.ac.ir</email></corresp></author-notes><pub-date pub-type="ppub"><month>5</month><year>2015</year></pub-date><volume>20</volume><issue>5</issue><fpage>477</fpage><lpage>482</lpage><history><date date-type="received"><day>01</day><month>10</month><year>2013</year></date><date date-type="rev-recd"><day>04</day><month>11</month><year>2013</year></date><date date-type="accepted"><day>06</day><month>7</month><year>2015</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2015 Journal of Research in Medical Sciences</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>Migarine is the most common headache around the world including Iran. In recent years, Vitamin D deficiency has been shown to a global health problem. A few studies have been determined inverse association between serum levels of Vitamin D with a headache. So, in this study, we investigated the effect of Vitamin D supplementation on symptoms and C-reactive protein (CRP) among patients with migraine.</p></sec><sec id="st2"><title>Materials and Methods:</title><p>This study was randomized, double-blind, and controlled-placebo clinical trial. Sixty-five migraine patients aged 10-61 years were included for analysis. Vitamin D was administrated for 10 weeks with 50,000 IU dosage of Vitamin D per week. Multivariate analysis of covariate and univariate analysis of covariate were done to determine the effects of Vitamin D supplementation on symptoms, including severity, duration, frequency of headache, and the headache diary result (HDR).</p></sec><sec id="st3"><title>Results:</title><p>Mean headache frequency and HDR had significant difference among two groups (5.9 &#x000b1; 7.0 vs. 7.0 &#x000b1; 6.0, <italic>P</italic> = 0.06 and 85.0 &#x000b1; 134.2 vs. 132.1 &#x000b1; 147.1, <italic>P</italic> = 0.04). But, a mean difference of headache frequency was marginally significant (<italic>P</italic> = 0.06). These values were lower among the intervention group compared to placebo group. The association was not observed between CRP with migraine disease.</p></sec><sec id="st4"><title>Conclusion:</title><p>In this study, we shown Vitamin D supplementation may be useful in decreasing frequency of headache attacks and HDR among patients with migraine.</p></sec></abstract><kwd-group><kwd>C-reactive protein</kwd><kwd>headache</kwd><kwd>migraine</kwd><kwd>Vitamin D</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Headache is prevalent among children and adolescents.[<xref rid="ref1" ref-type="bibr">1</xref>] The most common types of primary headache disorders are migraine and tension headaches, which involves 80% of people in the world.[<xref rid="ref2" ref-type="bibr">2</xref>]</p><p>Migraine is a neurological,[<xref rid="ref3" ref-type="bibr">3</xref>] progressive, debilitating, and chronic disorder.[<xref rid="ref4" ref-type="bibr">4</xref>] Migraine pains are caused by the release of pain-producing inflammatory materials around the nerves and blood vessels of the head.[<xref rid="ref5" ref-type="bibr">5</xref>]</p><p>The main feature of the migraine attacks are headache,[<xref rid="ref6" ref-type="bibr">6</xref>] last several hours to 2-3 days[<xref rid="ref5" ref-type="bibr">5</xref>] and is often intense,[<xref rid="ref6" ref-type="bibr">6</xref>] pulsatile, and unilateral.[<xref rid="ref5" ref-type="bibr">5</xref>] Another related symptoms include nausea, sometimes vomiting, sensitivity to light and sound,[<xref rid="ref5" ref-type="bibr">5</xref>] neck pain and muscle tension.[<xref rid="ref7" ref-type="bibr">7</xref>] Migraine is associated with approximately 2-fold more risk of ischemic attacks.[<xref rid="ref8" ref-type="bibr">8</xref>] Also, migraine in adults are related to seasonal allergies, asthma, epilepsy, continuous nightmares, atopic disorders, stroke, cardiovascular disorders, sleep problems, motion sickness, epistaxis, and in reproductive age is associated with preeclampsia and uterine bleeding.[<xref rid="ref1" ref-type="bibr">1</xref>] The most common reason of migraine is hunger or not eating adequate food, which is important specially among the young people.[<xref rid="ref6" ref-type="bibr">6</xref>] Migraine is nineteenth cause of disability worldwide[<xref rid="ref9" ref-type="bibr">9</xref>] that includes 10-20% of the population in the life.[<xref rid="ref10" ref-type="bibr">10</xref>] Recent information demonstrate that 1 out of 4 American adults, suffer from frequent or severe headache including migraine.[<xref rid="ref1" ref-type="bibr">1</xref>] The prevalence of migraine is more common in women compared with men.[<xref rid="ref6" ref-type="bibr">6</xref>] Prevalence of migraine in Turkey 16.4%,[<xref rid="ref11" ref-type="bibr">11</xref>] European adults 14.7%,[<xref rid="ref12" ref-type="bibr">12</xref>] England (7.6% in men and 18.3% in women),[<xref rid="ref13" ref-type="bibr">13</xref>] Germany 13.4%,[<xref rid="ref2" ref-type="bibr">2</xref>] Africa (3-7%)[<xref rid="ref5" ref-type="bibr">5</xref>] and in Asia (3% among men and 10% among women).[<xref rid="ref5" ref-type="bibr">5</xref>]</p><p>Also, a migraine headache is one of the common types of headaches in Iran.[<xref rid="ref14" ref-type="bibr">14</xref>]</p><p>In recent years, Vitamin D deficiency has been identified as a global health issue.[<xref rid="ref15" ref-type="bibr">15</xref>] Vitamin D deficiency has been identified among 30-80% children and adults in the world.[<xref rid="ref16" ref-type="bibr">16</xref>]</p><p>In Iran, the prevalence of Vitamin D deficiency is 75.1% in women and 72.1% in men.[<xref rid="ref17" ref-type="bibr">17</xref>] Vitamin D deficiency is related to different kinds of disorders including musculoskeletal disorders, cancer, autoimmune disorders, cardiovascular disorders, kidney disorders, mental disorders, skin disorders, etc.[<xref rid="ref18" ref-type="bibr">18</xref>] Previous studies have determined that lower levels of Vitamin D are associated with higher headache,[<xref rid="ref18" ref-type="bibr">18</xref><xref rid="ref19" ref-type="bibr">19</xref><xref rid="ref20" ref-type="bibr">20</xref><xref rid="ref21" ref-type="bibr">21</xref><xref rid="ref22" ref-type="bibr">22</xref>] but a few evidence have been determined. No clinical trial study has been performed in this field.</p><p>According to the previous findings, Vitamin D supplementation can decrease inflammatory factors such as C-reactive protein (CRP).[<xref rid="ref23" ref-type="bibr">23</xref>] Also according to theory of neurogenic inflammation in migraine pathogenesis[<xref rid="ref24" ref-type="bibr">24</xref><xref rid="ref25" ref-type="bibr">25</xref>] and because of increased CRP levels in response to inflammation among patients with migraine,[<xref rid="ref26" ref-type="bibr">26</xref><xref rid="ref27" ref-type="bibr">27</xref>] we assessed effect Vitamin D supplementation on CRP. So, the aim of present study is to investigate the effect of Vitamin D supplementation on symptoms and CRP among migraine patients.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>MATERIALS AND METHODS</title><p>The present study was randomized, double-blind clinical trial, and controlled with placebo. This study was performed among migraine patients in Isfahan city at Khorshid Clinic and Imam Mousa Sadr Clinic in autumn 2012. At baseline, 90 migraine patients aged 10-61 years participated. Confirmation of migraine disease was done by a neurologist. The informed consent form was taken from all participants. For ethical approval, the proposal was approved by the Ethics Committee of Isfahan University of Medical Sciences and was recorded in the website of Iranian Registry of Clinical Trials (IRCT2012122911763N4).</p><p>Data including age, gender, weight, height, waist circumference, body mass index (BMI), education, medical history, use of vitamin, and mineral supplements, migraine symptoms, serum levels of Vitamin D, calcium, phosphorus, albumin, and CRP were collected for all patients. BMI was calculated by the weight (kg) divided to squared height (m<sup>2</sup>).</p><p>Assessment form of migraine disease was completed by a neurologist for all participants.</p><p>Inclusion criteria were including confirmation of migraine disease by neurologist, tendency to participate in the study. And exclusion criteria contains cardiovascular, liver, kidney, primary hyperparathyroidism diseases, tension headache, and hypervitaminosis D, use of magnesium, calcium, B12, B9, B6, Vitamin D supplements, corticosteroids, and oral contraceptive in pregnancy.</p><p>All patients were referred for the laboratory to assess the serum levels of calcium, phosphorus, albumin, Vitamin D, CRP. Seventy-seven patients were placed in intervention and control groups. Thirty-nine patients in intervention group and 38 patients in the control group were located with simple randomization method. Patients were used supplementation or placebo of Vitamin D (50,000 IU/week) during 10 weeks (Zahravi company). The message was sent to all patients every week to remind participants for use of Vitamin D supplementation.</p><p>Also, 3-day food record were completed by patients every 2 weeks for dietary intakes. At the end, 65 patients were remained including 33 patients in intervention group and 32 patients in control group. At final, patients were examined for migraine symptoms (severity, mean duration of headache attacks, and frequency of attacks per month), and CRP.</p><p>Serum levels of Vitamin D were checked before and after the intervention. Food intakes of patients were analyzed using Nutritionist version 4 (N4) software to assess macronutrients and micronutrients.[<xref rid="ref28" ref-type="bibr">28</xref>]</p><sec id="sec2-1"><title>Biochemical assessment</title><p>At the first and end of the study, serum levels of 25(OH)D were measured by enzyme-linked immunosorbent assay (ELISA) method. According to ELISA method in laboratory, serum Vitamin D levels were categorized as: Deficient (serum levels &#x0003c;12 ng/ml); insufficient (serum levels between 12 and 30 ng/ml) and sufficient (serum levels more than 30 ng/ml). At first and the end of the intervention, CRP was measured. Also, for the diagnosis of primary hyperparathyroidism was measured calcium, phosphorus, and albumin at the first study.</p></sec><sec id="sec2-2"><title>Migraine assessment</title><p>Confirmation of migraine disease was done by a neurologist. For all patients, severity, mean duration of headache attacks and frequency of attacks per month was completed by a neurologist. Migraine severity was determined using Visual Analog Scale.[<xref rid="ref29" ref-type="bibr">29</xref><xref rid="ref30" ref-type="bibr">30</xref>] The headache diary result (HDR) was measured as: Duration of headache &#x000d7; frequency of headache.[<xref rid="ref29" ref-type="bibr">29</xref><xref rid="ref30" ref-type="bibr">30</xref>]</p></sec><sec id="sec2-3"><title>Statistical analysis</title><p>Statistical analysis was performed by the SPSS version 18.0 software (SPSS, Inc., Chicago, IL, USA). The presence or absence of difference in mean food intakes among two groups were analyzed by independent <italic>t</italic>-test. Severity, frequency, and duration of headaches attacks and HDR variables were not normal, so this variables changed on the logarithm until to be normal. Multivariate analysis of covariate including MANCOVA was done to determine the effects of Vitamin D supplementation on symptoms including severity, duration, and frequency of headache attacks. In addition, univariate analysis of covariate including ANCOVA was performed to investigate the effect of Vitamin D supplementation on HDR.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>In this study, 65 patients were enrolled in the intervention and control groups (33 patients in the intervention group and 32 patients in the control group). Twenty-five females and 8 males in the intervention group and 22 females and 10 males in the control group were enrolled. General and clinical information of patients are shown in <xref ref-type="table" rid="T1">Table 1</xref>. Thirty-three patients with mean age of 32.7 &#x000b1; 10.6 in the intervention group and 32 patients with mean age of 33.9 &#x000b1; 11.6 in the control group were enrolled. Mean BMI, waist circumference, and education levels were higher among control group in compared with the intervention group. The primary mean of migraine severity and frequency was higher in the intervention group in compared with control group. But, the primary average of migraine duration and HDR was higher in the control group compared to the intervention group. Also, secondary average of migraine severity, frequency, duration and HDR was higher in control group compared to intervention group, respectively, (5.9 &#x000b1; 1.5 vs. 5.0 &#x000b1; 2.0), (7.0 &#x000b1; 6.0 vs. 5.9 &#x000b1; 7.0), (21.7 &#x000b1; 17.0 vs. 13.6 &#x000b1; 4.0), (132.1 &#x000b1; 147.1 vs. 85.0 &#x000b1; 134.2).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>General and clinical characteristics of patients with migraine</p></caption><graphic xlink:href="JRMS-20-477-g001"/></table-wrap><p>Deficiency, insufficiency, and sufficiency of Vitamin D were reported among 15.4%, 66.1% and 18.5% patients, respectively.</p><p>Food intakes were analyzed with the software. These results are shown in <xref ref-type="table" rid="T2">Table 2</xref>. No significant difference was observed between mean dietary intakes of patients among the intervention and control groups.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Food intakes of patients according to intervention and control groups</p></caption><graphic xlink:href="JRMS-20-477-g002"/></table-wrap><p>Multivariate analysis of covariate was used to determine the mean difference of severity, frequency, and headache duration in intervention and control groups. But for a mean difference of HDR in two groups, we used from univariate analysis of covariate. Severity, frequency, and duration of headaches attacks and HDR variables were not normal, so this variables changed on the logarithm until to be normal.</p><p>Multivariate analysis of covariance for age, sex, waist circumference, education, BMI, primary Vitamin D levels, primary severity, primary frequency, and duration of headache were controlled. In univariate analysis of covariate were controlled previous variables and, in addition, primary HDR. Results of the average comparison of severity, frequency, duration and HDR among intervention and control groups are shown in <xref ref-type="table" rid="T3">Table 3</xref>.</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Comparison of severity, frequency, duration and HDR in intervention group and control group</p></caption><graphic xlink:href="JRMS-20-477-g003"/></table-wrap><p>No significant difference was observed for mean severity and duration headache attacks among two groups. But, a mean difference of headache frequency was marginally significant (<italic>P</italic> = 0.06) and mean frequency of migraine was lower among intervention group to compared with control group (5.9 &#x000b1; 7.0 vs. 7.0 &#x000b1; 6.0). Mean HDR had significant difference among two groups (<italic>P</italic> = 0.04) that mean HDR was lower in the intervention group and compared to control group (85.0 &#x000b1; 134.2 vs. 132.1 &#x000b1; 147.1).</p><p>Two patients had positive CRP, however, other patients were negative CRP. One of two patients with positive CRP refused to continue. Thus, we can conclude that there were not a relationship between CRP with migraine.</p></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>In the present study, there was a significant difference in the mean daily headache among the intervention and control groups. Also, the mean difference in headache frequency was significance threshold between two groups. But, no association was shown in migraine with CRP.</p><p>In three case-report studies have been shown the role of Vitamin D in headache, including migraine.[<xref rid="ref18" ref-type="bibr">18</xref><xref rid="ref20" ref-type="bibr">20</xref><xref rid="ref21" ref-type="bibr">21</xref>] Thys-Jacobs performed two case-reports on this issue in 1994.[<xref rid="ref20" ref-type="bibr">20</xref><xref rid="ref21" ref-type="bibr">21</xref>] A case-report study was performed in two female patients with migraine headache related to menstruation and premenstrual syndrome. In these two patients with low Vitamin D levels and with use of Vitamin D and calcium supplements (1600-1200 IU/day) were found significant decrease in migraine attacks and premenstrual symptoms in 2 months treatment.[<xref rid="ref20" ref-type="bibr">20</xref>] Next study, was conducted among postmenopausal patients with migraine headache and low Vitamin D levels which with use of Vitamin D and calcium supplementations decreased the frequency and duration of migraine attacks, but the study was case-report study.[<xref rid="ref21" ref-type="bibr">21</xref>] Prakash and Shah have been reported that use of Vitamin D and calcium supplementations (1500 IU Vitamin D3 and 1000 mg calcium per day) can be effective in headache improvement during 4-6 weeks. Although, Vitamin D was probably more important than compared with calcium in headache improvement.[<xref rid="ref18" ref-type="bibr">18</xref>]</p><p>Two studies have found an inverse relationship between the serum Vitamin D levels with a headache.[<xref rid="ref19" ref-type="bibr">19</xref><xref rid="ref22" ref-type="bibr">22</xref>]</p><p>In 2008, Turner <italic>et al.</italic> reported that the prevalence of Vitamin D deficiency were 26% in 267 patients with chronic pain (25 patients with a headache).[<xref rid="ref31" ref-type="bibr">31</xref>]</p><p>In a study performed in Norway, an inverse association was determined between headache with Vitamin D and also, the association was observed with adjustment for different variables such as age, sex, season, and geographical region.[<xref rid="ref22" ref-type="bibr">22</xref>]</p><p>Wheeler have found that migraine patients have low levels of Vitamin D.[<xref rid="ref32" ref-type="bibr">32</xref>] Prevalence and frequency of headaches was reported greater in Northern regions and areas with mean low temperature than in Southern regions in Greece.[<xref rid="ref33" ref-type="bibr">33</xref>]</p><p>Serum levels of Vitamin D are higher among people in the lower latitudes that is a main factor for the low headache prevalence.[<xref rid="ref15" ref-type="bibr">15</xref>]</p><p>In the else study, a significant association was not shown between serum Vitamin D levels and migraine headache, but significant relationship between nonmigraine headache with serum levels of Vitamin D was determined among nonsmokers group.[<xref rid="ref19" ref-type="bibr">19</xref>]</p><p>In a study performed in Isfahan in autumn 2012 by Mottaghi <italic>et al.</italic>, positive weak association was seen between serum levels of Vitamin D with HDR (<italic>P</italic> = 0.04, <italic>r</italic> = 0.19) and this relationship remained significant after adjusting confounding variables.[<xref rid="ref30" ref-type="bibr">30</xref>]</p><p>One theory of migraine pathogenesis is neurogenic inflammation.[<xref rid="ref24" ref-type="bibr">24</xref><xref rid="ref25" ref-type="bibr">25</xref>] The CRP level, a marker of inflammation[<xref rid="ref26" ref-type="bibr">26</xref>] and an acute-phase protein in blood, increases in response to inflammation.[<xref rid="ref24" ref-type="bibr">24</xref>] CRP level has been described to be abnormal among patients with migraine, probably through vascular inflammation.[<xref rid="ref26" ref-type="bibr">26</xref><xref rid="ref27" ref-type="bibr">27</xref>]</p><p>Welch <italic>et al.</italic> reported a clinical report of 60 patients with migraine.[<xref rid="ref27" ref-type="bibr">27</xref>] Findings demonstrated that 43% of the patients had increased CRP (defined as &#x0003e;3 mg/l), with a higher ratio in the patients without aura than in the patients with aura.[<xref rid="ref27" ref-type="bibr">27</xref>]</p><p>A case&#x02013;control study of 50 patients with migraine and 50 controls reported CRP level among migraineurs was higher (1.42 mg/l) compared to controls (0.90 mg/l) (<italic>P</italic> = 0.03).[<xref rid="ref34" ref-type="bibr">34</xref>] CRP level was higher in patients without aura compared to controls, 2.11 mg/l versus 0.90 mg/l (<italic>P</italic> = 0.0002).[<xref rid="ref34" ref-type="bibr">34</xref>]</p><p>Also, a Cohort study showed that CRP level was higher among patients with a history of migraine than in the women with no migraine history.[<xref rid="ref35" ref-type="bibr">35</xref>] serum CRP levels were higher in the women without aura compared to women with aura.[<xref rid="ref35" ref-type="bibr">35</xref>]</p><p>So, findings from these studies, suggest that CRP is modestly elevated among patients with migraine compared to controls.[<xref rid="ref26" ref-type="bibr">26</xref>] But in our study, we didn't observe the relationship between CRP with migraine.</p><p>Amer and Qayyum reported a statistically significant inverse relationship between 25(OH)D at serum levels lower than 21 ng/ml with CRP. But described that 25(OH)D at serum level &#x02265;21 ng/ml is associated with an increase in serum CRP. So, the role of Vitamin D supplementation to decrease inflammation is useful only among adults with lower serum 25(OH)D.[<xref rid="ref23" ref-type="bibr">23</xref>]</p><p>The role of Vitamin D deficiency in the cause of headache is unfamiliar.[<xref rid="ref15" ref-type="bibr">15</xref>]</p><p>The presence of alpha 1-hydroxylase enzyme, Vitamin D receptors and Vitamin D binding protein in the brain, especially hypothalamus[<xref rid="ref15" ref-type="bibr">15</xref>] and low levels of magnesium[<xref rid="ref18" ref-type="bibr">18</xref>] are the mechanism about the association between Vitamin D deficiency and headache. Because intestinal absorption of magnesium is dependent on Vitamin D.[<xref rid="ref18" ref-type="bibr">18</xref>]</p><p>The strength of this study is the first clinical trial study in the world about the effect of Vitamin D supplementation on symptoms and CRP in patients with migraine. Sunlight exposure assessment was not measured in this study and was one limitation of our studies.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>CONCLUSION</title><p>In summary, the present study showed that Vitamin D supplementation on the frequency and headaches diary result can be effective, although the effect on migraine frequency was significance threshold. But, no association was seen between migraine with CRP levels. Thus, it is required to do further clinical trial studies with larger sample size.</p></sec><sec id="sec1-6"><title>AUTHOR'S CONTRIBUTIONS</title><p>TM, FK, GA, RG designed, conducted and edited the manuscript. MM analyzed and interpreted data. All authors read and approved the final manuscript.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>The present study was supported by a grant (No. 391212) from Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. We are grateful to Food Security Research Center in Isfahan.</p></ack><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflicts of Interest:</bold> No conflict of interests.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lateef</surname><given-names>TM</given-names></name><name><surname>Cui</surname><given-names>L</given-names></name><name><surname>Nelson</surname><given-names>KB</given-names></name><name><surname>Nakamura</surname><given-names>EF</given-names></name><name><surname>Merikangas</surname><given-names>KR</given-names></name></person-group><article-title>Physical comorbidity of migraine and other headaches in US adolescents</article-title><source>J Pediatr</source><year>2012</year><volume>161</volume><fpage>308</fpage><lpage>13.e1</lpage><pub-id pub-id-type="pmid">22381023</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>MS</given-names></name><name><surname>Katsarava</surname><given-names>Z</given-names></name><name><surname>Obermann</surname><given-names>M</given-names></name><name><surname>Fritsche</surname><given-names>G</given-names></name><name><surname>Oezyurt</surname><given-names>M</given-names></name><name><surname>Kaesewinkel</surname><given-names>K</given-names></name><etal/></person-group><article-title>Prevalence of primary headaches in Germany: Results of the German Headache Consortium Study</article-title><source>J Headache Pain</source><year>2012</year><volume>13</volume><fpage>215</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">22395638</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battista</surname><given-names>J</given-names></name><name><surname>Badcock</surname><given-names>DR</given-names></name><name><surname>McKendrick</surname><given-names>AM</given-names></name></person-group><article-title>Migraine increases centre-surround suppression for drifting visual stimuli</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e18211</fpage><pub-id pub-id-type="pmid">21494594</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inaloo</surname><given-names>S</given-names></name><name><surname>Dehghani</surname><given-names>SM</given-names></name><name><surname>Farzadi</surname><given-names>F</given-names></name><name><surname>Haghighat</surname><given-names>M</given-names></name><name><surname>Imanieh</surname><given-names>MH</given-names></name></person-group><article-title>A comparative study of celiac disease in children with migraine headache and a normal control group</article-title><source>Turk J Gastroenterol</source><year>2011</year><volume>22</volume><fpage>32</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">21480108</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="webpage"><article-title>Headache Disorders</article-title><date-in-citation>Last accessed on 2004 Mar</date-in-citation><comment>Available from:
<uri xlink:type="simple" xlink:href="http://www.who.int/mediacentre/factsheets/fs277/en/">http://www.who.int/mediacentre/factsheets/fs277/en/</uri></comment></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>TJ</given-names></name></person-group><article-title>Lifting the Burden: The Global Campaign to Reduce the Burden of Headache Worldwide. Aids for management of common headache disorders in primary care</article-title><source>J Headache Pain</source><year>2007</year><volume>8</volume><fpage>S26</fpage><lpage>9</lpage></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unalp</surname><given-names>A</given-names></name><name><surname>Dirik</surname><given-names>E</given-names></name><name><surname>Kurul</surname><given-names>S</given-names></name></person-group><article-title>Prevalence and clinical findings of migraine and tension-type headache in adolescents</article-title><source>Pediatr Int</source><year>2007</year><volume>49</volume><fpage>943</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18045302</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000fc;rks</surname><given-names>M</given-names></name></person-group><article-title>Genetics of migraine in the age of genome-wide association studies</article-title><source>J Headache Pain</source><year>2012</year><volume>13</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">22072275</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahdavi</surname><given-names>R</given-names></name><name><surname>Tarighat Esfanjani</surname><given-names>A</given-names></name><name><surname>Ebrahimi</surname><given-names>M</given-names></name><name><surname>Talebi</surname><given-names>M</given-names></name><name><surname>Ghaemmaghami</surname><given-names>J</given-names></name></person-group><article-title>Effects of oral magnesium for migraine prophylaxis</article-title><source>J Pharm Sci</source><year>2009</year><volume>15</volume><fpage>103</fpage><lpage>8</lpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000fc;rks</surname><given-names>M</given-names></name><name><surname>Rist</surname><given-names>PM</given-names></name><name><surname>Bigal</surname><given-names>ME</given-names></name><name><surname>Buring</surname><given-names>JE</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Kurth</surname><given-names>T</given-names></name></person-group><article-title>Migraine and cardiovascular disease: Systematic review and meta-analysis</article-title><source>BMJ</source><year>2009</year><volume>339</volume><fpage>b3914</fpage><pub-id pub-id-type="pmid">19861375</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ertas</surname><given-names>M</given-names></name><name><surname>Baykan</surname><given-names>B</given-names></name><name><surname>Orhan</surname><given-names>EK</given-names></name><name><surname>Zarifoglu</surname><given-names>M</given-names></name><name><surname>Karli</surname><given-names>N</given-names></name><name><surname>Saip</surname><given-names>S</given-names></name><etal/></person-group><article-title>One-year prevalence and the impact of migraine and tension-type headache in Turkey: A nationwide home-based study in adults</article-title><source>J Headache Pain</source><year>2012</year><volume>13</volume><fpage>147</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">22246025</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stovner</surname><given-names>LJ</given-names></name><name><surname>Andree</surname><given-names>C</given-names></name></person-group><article-title>Prevalence of headache in Europe: A review for the Eurolight project</article-title><source>J Headache Pain</source><year>2010</year><volume>11</volume><fpage>289</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">20473702</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>TJ</given-names></name><name><surname>Scher</surname><given-names>AI</given-names></name><name><surname>Stewart</surname><given-names>WF</given-names></name><name><surname>Kolodner</surname><given-names>K</given-names></name><name><surname>Liberman</surname><given-names>J</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name></person-group><article-title>The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity</article-title><source>Cephalalgia</source><year>2003</year><volume>23</volume><fpage>519</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">12950377</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safavi</surname><given-names>M</given-names></name><name><surname>Nazari</surname><given-names>F</given-names></name><name><surname>Mahmoody</surname><given-names>M</given-names></name></person-group><article-title>The relationship of migraine headache and life style among women</article-title><source>Iran J Nurs</source><year>2008</year><volume>21</volume><fpage>89</fpage><lpage>100</lpage></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prakash</surname><given-names>S</given-names></name><name><surname>Mehta</surname><given-names>NC</given-names></name><name><surname>Dabhi</surname><given-names>AS</given-names></name><name><surname>Lakhani</surname><given-names>O</given-names></name><name><surname>Khilari</surname><given-names>M</given-names></name><name><surname>Shah</surname><given-names>ND</given-names></name></person-group><article-title>The prevalence of headache may be related with the latitude: A possible role of Vitamin D insufficiency?</article-title><source>J Headache Pain</source><year>2010</year><volume>11</volume><fpage>301</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">20464624</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andiran</surname><given-names>N</given-names></name><name><surname>&#x000c7;elik</surname><given-names>N</given-names></name><name><surname>Ak&#x000e7;a</surname><given-names>H</given-names></name><name><surname>Dogan</surname><given-names>G</given-names></name></person-group><article-title>Vitamin D deficiency in children and adolescents</article-title><source>J Clin Res Pediatr Endocrinol</source><year>2012</year><volume>4</volume><fpage>25</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">22394709</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moradzadeh</surname><given-names>K</given-names></name><name><surname>Larijani</surname><given-names>B</given-names></name><name><surname>Keshtkar</surname><given-names>AA</given-names></name><name><surname>Hossein-Nezhad</surname><given-names>A</given-names></name><name><surname>Rajabian</surname><given-names>R</given-names></name><name><surname>Nabipour</surname><given-names>I</given-names></name><etal/></person-group><article-title>Normative values of Vitamin D among Iranian population: A population based study</article-title><source>Int J Osteoporos Metab Dis</source><year>2008</year><volume>1</volume><fpage>8</fpage><lpage>15</lpage></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prakash</surname><given-names>S</given-names></name><name><surname>Shah</surname><given-names>ND</given-names></name></person-group><article-title>Chronic tension-type headache with Vitamin D deficiency: Casual or causal association?</article-title><source>Headache</source><year>2009</year><volume>49</volume><fpage>1214</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">19619241</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kjaergaard</surname><given-names>M</given-names></name><name><surname>Eggen</surname><given-names>AE</given-names></name><name><surname>Mathiesen</surname><given-names>EB</given-names></name><name><surname>Jorde</surname><given-names>R</given-names></name></person-group><article-title>Association between headache and serum 25-hydroxyvitamin D: The Troms&#x000f8; Study: Troms&#x000f8; 6</article-title><source>Headache</source><year>2012</year><volume>52</volume><fpage>1499</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">22973803</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thys-Jacobs</surname><given-names>S</given-names></name></person-group><article-title>Vitamin D and calcium in menstrual migraine</article-title><source>Headache</source><year>1994</year><volume>34</volume><fpage>544</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8002332</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thys-Jacobs</surname><given-names>S</given-names></name></person-group><article-title>Alleviation of migraines with therapeutic Vitamin D and calcium</article-title><source>Headache</source><year>1994</year><volume>34</volume><fpage>590</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">7843955</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knutsen</surname><given-names>KV</given-names></name><name><surname>Brekke</surname><given-names>M</given-names></name><name><surname>Gjelstad</surname><given-names>S</given-names></name><name><surname>Lagerl&#x000f8;v</surname><given-names>P</given-names></name></person-group><article-title>Vitamin D status in patients with musculoskeletal pain, fatigue and headache: A cross-sectional descriptive study in a multi-ethnic general practice in Norway</article-title><source>Scand J Prim Health Care</source><year>2010</year><volume>28</volume><fpage>166</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">20642395</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amer</surname><given-names>M</given-names></name><name><surname>Qayyum</surname><given-names>R</given-names></name></person-group><article-title>Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006)</article-title><source>Am J Cardiol</source><year>2012</year><volume>109</volume><fpage>226</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">21996139</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000fc;zel</surname><given-names>I</given-names></name><name><surname>Tasdemir</surname><given-names>N</given-names></name><name><surname>Celik</surname><given-names>Y</given-names></name></person-group><article-title>Evaluation of serum transforming growth factor &#x000df;1 and C-reactive protein levels in migraine patients</article-title><source>Neurol Neurochir Pol</source><year>2013</year><volume>47</volume><fpage>357</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">23986426</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalessio</surname><given-names>DJ</given-names></name></person-group><article-title>Vascular permeability and vasoactive substances: Their relationship to migraine</article-title><source>Adv Neurol</source><year>1974</year><volume>4</volume><fpage>395</fpage><lpage>401</lpage></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gudmundsson</surname><given-names>LS</given-names></name><name><surname>Aspelund</surname><given-names>T</given-names></name><name><surname>Scher</surname><given-names>AI</given-names></name><name><surname>Thorgeirsson</surname><given-names>G</given-names></name><name><surname>Johannsson</surname><given-names>M</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><etal/></person-group><article-title>C-reactive protein in migraine sufferers similar to that of non-migraineurs: The Reykjavik Study</article-title><source>Cephalalgia</source><year>2009</year><volume>29</volume><fpage>1301</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">19438929</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welch</surname><given-names>KM</given-names></name><name><surname>Brandes</surname><given-names>AW</given-names></name><name><surname>Salerno</surname><given-names>L</given-names></name><name><surname>Brandes</surname><given-names>JL</given-names></name></person-group><article-title>C-reactive protein may be increased in migraine patients who present with complex clinical features</article-title><source>Headache</source><year>2006</year><volume>46</volume><fpage>197</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16492227</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadre-Jahani</surname><given-names>S</given-names></name><name><surname>Abolhassani</surname><given-names>M</given-names></name><name><surname>Dehghani</surname><given-names>S</given-names></name><name><surname>Jalili</surname><given-names>M</given-names></name><name><surname>Talebpour</surname><given-names>M</given-names></name><name><surname>Imani</surname><given-names>H</given-names></name><etal/></person-group><article-title>Relationship between nutrient intake and body composition one year after bariatric surgery</article-title><source>Int Res J Appl Basic Sci</source><year>2014</year><volume>8</volume><fpage>81</fpage><lpage>7</lpage></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asadi</surname><given-names>B</given-names></name><name><surname>Khorvash</surname><given-names>F</given-names></name><name><surname>Najaran</surname><given-names>A</given-names></name><name><surname>Khorvash</surname><given-names>F</given-names></name></person-group><article-title>Cyproheptadine versus propranolol in the prevention of migraine headaches in children</article-title><source>Pak J Med Sci</source><year>2012</year><volume>28</volume><fpage>309</fpage><lpage>11</lpage></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mottaghi</surname><given-names>T</given-names></name><name><surname>Khorvash</surname><given-names>F</given-names></name><name><surname>Askari</surname><given-names>G</given-names></name><name><surname>Maracy</surname><given-names>MR</given-names></name><name><surname>Ghiasvand</surname><given-names>R</given-names></name><name><surname>Maghsoudi</surname><given-names>Z</given-names></name><etal/></person-group><article-title>The relationship between serum levels of Vitamin D and migraine</article-title><source>J Res Med Sci</source><year>2013</year><volume>18</volume><fpage>S66</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">23961291</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>MK</given-names></name><name><surname>Hooten</surname><given-names>WM</given-names></name><name><surname>Schmidt</surname><given-names>JE</given-names></name><name><surname>Kerkvliet</surname><given-names>JL</given-names></name><name><surname>Townsend</surname><given-names>CO</given-names></name><name><surname>Bruce</surname><given-names>BK</given-names></name></person-group><article-title>Prevalence and clinical correlates of Vitamin D inadequacy among patients with chronic pain</article-title><source>Pain Med</source><year>2008</year><volume>9</volume><fpage>979</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">18346069</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname><given-names>SD</given-names></name></person-group><article-title>Vitamin D deficiency in chronic migraine</article-title><source>Headache</source><year>2008</year><volume>48</volume><fpage>S52</fpage><lpage>3</lpage></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitsikostas</surname><given-names>DD</given-names></name><name><surname>Tsaklakidou</surname><given-names>D</given-names></name><name><surname>Athanasiadis</surname><given-names>N</given-names></name><name><surname>Thomas</surname><given-names>A</given-names></name></person-group><article-title>The prevalence of headache in Greece: Correlations to latitude and climatological factors</article-title><source>Headache</source><year>1996</year><volume>36</volume><fpage>168</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">8984090</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanmolkot</surname><given-names>FH</given-names></name><name><surname>de Hoon</surname><given-names>JN</given-names></name></person-group><article-title>Increased C-reactive protein in young adult patients with migraine</article-title><source>Cephalalgia</source><year>2007</year><volume>27</volume><fpage>843</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17668468</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurth</surname><given-names>T</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Buring</surname><given-names>JE</given-names></name></person-group><article-title>Migraine and biomarkers of cardiovascular disease in women</article-title><source>Cephalalgia</source><year>2008</year><volume>28</volume><fpage>49</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">17986270</pub-id></element-citation></ref></ref-list></back></article>